This microneedle patch could someday replace a needle for delivering COVID-19 vaccines.
Credit: Adapted from ACS Nano 2021, DOI: 10.1021/acsnano.1c03252
More than 2 billion people worldwide are fully vaccinated against COVID-19. However, many who live in resource-limited countries haven’t been able to get vaccines, partly because these areas lack temperature-controlled shipping and storage facilities. Now, researchers reporting in ACS Nano have developed a microneedle patch that delivers a COVID-19 DNA vaccine into the skin, causing strong immune responses in cells and mice. Importantly, the patch can be stored for over 30 days at room temperature.
To date, the U.S. Food and Drug Administration has authorized three vaccines for use during the COVID-19 pandemic: one based on protein, and two on RNA. All of them must be kept refrigerated or frozen, which limits their distribution to remote or resource-limited areas. In addition, the vaccines must be administered by a healthcare worker as an injection into a muscle. Because immune cells aren’t typically found in muscles, scientists have investigated various ways to deliver vaccines into the skin, which contains abundant antigen-presenting cells (APCs) and could therefore generate a stronger immune response. Hui Li, Guangjun Nie, Hai Wang and colleagues wanted to develop a microneedle patch that efficiently delivers a COVID-19 vaccine under the skin, causing potent and durable immunity without the need for a cold chain or painful injections.
The researchers based their vaccine on DNA, which is easier to make than RNA or protein. It’s also more stable than RNA. However, in clinical trials, intramuscular DNA vaccines have been limited in their effectiveness because, unlike RNA or protein, the DNA must find its way inside the cell nucleus to work. By delivering the vaccine into APC-rich skin rather than muscle, the researchers reasoned that they could increase the chances that the DNA would enter the nucleus of an APC.
To make their delivery system, the team attached DNA sequences encoding either the SARS-CoV-2 spike protein or nucleocapsid protein to the surface of non-toxic nanoparticles. Inside the nanoparticles was an adjuvant — a molecule that helps stimulate an immune response. Then, the researchers coated a microneedle patch with the vaccine nanoparticles. The small rectangular patch contained 100 biodegradable microneedles, each less than 1/10 the diameter of a bee’s stinger, that could painlessly penetrate the skin’s outer layer. The researchers tested the system in mice, showing that the spike-protein-encoding microneedle patch caused strong antibody and T-cell responses, with no observable side effects. Because the vaccine patches can be stored at room temperature for at least 30 days without losing efficacy, they could be an important tool for developing COVID-19 vaccines with global accessibility, the researchers say.
Original Article: Microneedle patch delivers COVID-19 DNA vaccine; doesn’t require cold storage
More from: American Chemical Society | Chinese Academy of Sciences
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Microneedle patch
- Micro Needle Patch Market Size Worth USD 1,034.5 Million in 2028 | Emergen Researchon July 28, 2022 at 9:20 am
According to the most recent report by Emergent Research, the worldwide micro-needle patch market is anticipated to reach a market size of USD 639.4 Million at a revenue CAGR of 6.1 percent in 2028.
- A Fremont company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M.on July 26, 2022 at 3:14 pm
Drug-patch developer @ZosanoPharma looks to sell its assets through bankruptcy court for $1 million. #migraine $ZSANQ ...
- East Bay company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1Mon July 26, 2022 at 7:23 am
Emergex has used Zosano's system — an array of about 2,000 drug-coated titanium microneedles on an adhesive patch — as well as another microneedle technology from NanoPass Technologies Ltd. of ...
- Cutaneous Reactions to Transdermal Therapeutic Systemson July 19, 2022 at 5:00 pm
Teriparatide is being investigated for use in a transdermal microneedle patch. This medication has historically been delivered by daily subcutaneous injection to treat osteoporosis. The ...
- PharmaTher Announces Positive Results from Study For Ketamine Microneedle Patchon July 13, 2022 at 2:51 am
Characterization of drug recovery and stability before drug permeation from films via hydrogel-forming microneedle array patches (“MAP”) was assessed in vitro using the Franz cell apparatus. Based on ...
Go deeper with Google Headlines on:
Microneedle patch
Go deeper with Bing News on:
Biodegradable microneedles
- Micro Needle Patch Market Size Worth USD 1,034.5 Million in 2028 | Emergen Researchon July 28, 2022 at 9:20 am
According to the most recent report by Emergent Research, the worldwide micro-needle patch market is anticipated to reach a market size of USD 639.4 Million at a revenue CAGR of 6.1 percent in 2028.
- Biodegradable Urethane’s Potential for Drug-Delivery Implantson July 12, 2022 at 5:00 pm
PGSU is a biodegradable, flexible elastomer that is known to have ... such as a rod-shaped implant, microspheres, microneedles, fibers, sheets, and scaffolds of various geometries. Hydralese (PGSU) ...
- Researchers develop novel antibody test which detects COVID without blood sampleon July 7, 2022 at 8:09 pm
"First, we developed biodegradable porous microneedles made of polylactic acid that draws up the ISF from human skin. Then, we constructed a paper-based immunoassay biosensor for the detection of ...
- Skin Patch Test Detects COVID-19 in Under Three Minuteson July 5, 2022 at 1:00 am
2022] “We developed biodegradable porous microneedles made of polylactic acid that draws up the interstitial fluid from human skin,” said Beomjoon Kim, PhD, professor at the department of ...
- Can a Patch Test Help Detect COVID?on July 1, 2022 at 1:15 pm
"First, we developed biodegradable porous microneedles made of polylactic acid that draws up the ISF from human skin. Then, we constructed a paper-based immunoassay biosensor for the detection of ...